HEALTHSOUTH Announces Receipt Of Consents Necessary To Enter Into Supplemental Indentures

BIRMINGHAM, Ala., Feb. 15 /PRNewswire-FirstCall/ -- HealthSouth Corporation announced today that as of 5:00 PM, New York City time, it had received the necessary consents of the holders of each series of the notes listed in the table below (the "Notes") to the proposed amendments to the applicable indenture governing each series of the Notes. The proposed amendments are described in more detail in the Offers to Purchase and Consent Solicitations Statement, dated February 2, 2006 (the "Statement").

CUSIP/ISIN Number Aggregate Outstanding Title of Principal Amount Security 421924AU5/US421924AU54 $180,300,000 7.375% Senior Notes due 2006 421924AR2/US421924AR26 $343,000,000 8.500% Senior Notes due 2008 421924AM3/US421924AM39 $250,000,000 7.000% Senior Notes due 2008 421924AP6/US421924AP69 $319,260,000 10.750% Senior Subordinated Notes due 2008 421924AX9/US421924AX93 421924AV3/US421924AV38 $347,700,000 8.375% Senior Notes due 2011 421924AZ4/US421924AZ42 421924AY7/US421924AY76 $908,700,000 7.625% Senior Notes due 2012

HealthSouth promptly executed supplemental indentures implementing the proposed amendments, but such supplemental indentures will not become operative until and unless HealthSouth accepts for purchase all of the Notes properly tendered in the related tender offers. HealthSouth's obligation to accept for purchase and to pay for Notes properly tendered and not withdrawn according to the terms of the Statement is subject to the satisfaction of certain conditions which are described in the Statement.

The tender offers are scheduled to expire at 12:00 midnight, New York City time, on the evening of March 2, 2006, unless extended or earlier terminated. However, no consent payments will be made in respect of Notes tendered after the consent payment deadline as specified in the Statement. Holders who validly tender their Notes will receive payment on or about March 3, 2006, unless the applicable offer is extended or earlier terminated, and will also receive accrued and unpaid interest from the last interest payment date to, but not including, the date the Holders receive such payment.

This announcement is neither an offer to purchase, nor a solicitation of an offer to purchase, nor a solicitation of tenders or consents with respect to, any Notes. The tender offers and the consent solicitations are being made solely pursuant to the Statement and the related Consent and Letter of Transmittal.

Requests for documents may be directed to Global Bondholder Services Corporation, the depositary and information agent for the offers, at 212-430-3774 (collect) or 866-804-2200 (U.S. toll-free). Additional information concerning the tender offers and consent solicitations may be obtained by contacting Merrill Lynch & Co., Liability Management, (888) ML4-TNDR (U.S. toll-free) or (212) 449-4914 (collect), Citigroup Corporate and Investment Banking, Liability Management Group, (800) 558-3745 (U.S. toll-free) or (212) 723-6106 (collect) or J.P. Morgan Securities Inc., (866) 834-8666 (U.S. toll free) or (212) 834-4388 (collect).

About HealthSouth

HealthSouth is one of the nation's largest providers of outpatient surgery, diagnostic imaging and rehabilitative healthcare services, operating facilities nationwide. HealthSouth can be found on the Web at www.healthsouth.com.

Statements contained in this press release which are not historical facts are forward-looking statements. In addition, HealthSouth, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. HealthSouth's actual results may differ materially from the results anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual results to differ materially from those estimated by HealthSouth include, but are not limited to: the investigation by the Department of Justice into HealthSouth's financial reporting and related activity calling into question the accuracy of the Company's previously filed financial statements; the outcome of pending litigation relating to these matters; significant changes in HealthSouth's management team; HealthSouth's ability to successfully refinance its existing indebtedness as it becomes due; HealthSouth's ability to continue to operate in the ordinary course and manage its relationships with its creditors, including its lenders, bondholders, vendors and suppliers, employees and customers; HealthSouth's ability to successfully remediate its internal control weaknesses; changes, delays in or suspension of reimbursement for HealthSouth's services by governmental or private payors; changes in the regulation of the healthcare industry at either or both of the federal and state levels; competitive pressures in the healthcare industry and HealthSouth's response thereto; HealthSouth's ability to obtain and retain favorable arrangements with third-party payors; HealthSouth's ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages; general conditions in the economy and capital markets; and other factors which may be identified from time to time in the Company's SEC filings and other public announcements, including HealthSouth's Form 10-K for the year ended December 31, 2004.

Media Contact

Andy Brimmer, 205-410-2777

HealthSouth Corporation

CONTACT: Andy Brimmer of HealthSouth Corporation, +1-205-410-2777

Back to news